Trade Summary

4 days ago, Muken Ross, serving as Chief Executive Officer at SOPHiA GENETICS SA (SOPH), sold 9,838 shares at $5.22 per share, for a total transaction value of $51,354.36. Following this transaction, Muken Ross now holds 670,651 shares of SOPH.

This sale represents a 1.45% decrease in Muken Ross's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 4:03 PM ET, 1 day after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.